in mammary epithelia
, decreased RT by 155 ⍀ ⅐ cm 2 , and largely eliminated responses to amiloride. Whole cell patch-clamp measurements demonstrated amiloride-inhibited Na ϩ currents [linear current-voltage (I-V) relation] and forskolin-stimulated Cl Ϫ currents (linear I-V relation). A capacitance probe method showed that in the control state, MEC monolayers either absorbed or secreted fluid (2-4 l ⅐ cm Ϫ2 ⅐ h Ϫ1 ). Fluid secretion was stimulated either by activating CFTR (cAMP) or blocking ENaC (amiloride). These data plus equivalent circuit analysis showed that 1) fluid absorption across MEC is mediated by Na ϩ transport via apical membrane ENaC, and fluid secretion is mediated, in part, by Cl Ϫ transport via apical CFTR; 2) in both cases, appropriate counterions move through tight junctions to maintain electroneutrality; and 3) interactions among CFTR, ENaC, and tight junctions allow MEC to either absorb or secrete fluid and, in situ, may help control luminal [ , and 12 mM Cl Ϫ and is mildly acidic (pH 6.8) (34) . The initial secretion of milk by the acinar cells probably occurs as an isotonic fluid, largely driven by the production and then secretion of lactose and osmotically obliged fluid. The duct cells likely modify this fluid as it moves along the duct and passes out to the nipple. It is possible that the relatively low ionic content of milk is either generated or maintained by the reabsorptive properties of acinar and duct cells, but the specific ion channels and other transporters involved have not been described.
Abnormal fluid accumulation in the breast is common in premenopausal women (5, 6, 21, 30) . As part of a project to determine how mammary cysts accumulate fluid, we began a study of the ion transport properties of the mammary epithelial cell line 31EG4. This untransformed mouse cell line appears to have properties of both acinar and ductal mammary epithelia cells (39, 42, 48) . Previous experiments on primary cultures of mouse mammary epithelial cells, which are a mixture of duct and acinar cells (4) , showed that Na ϩ is actively absorbed, that this absorption is stimulated by the lactogenic hormone prolactin, and that absorption is inhibited by apical amiloride, the well-known blocker of the epithelial Na ϩ channel (ENaC) (19) . 31EG4 cells form polarized monolayers with tight junctions that are regulated in their "tightness" by the glucocorticoid dexamethasone, which can stop growth and induce differentiation (48) . This process includes an increase in transepithelial resistance (R T ) from 100-300 ⍀ ⅐ cm 2 to Ͼ700-1,000 ⍀ ⅐ cm 2 and the appearance of tight junctional proteins ZO-1 and more "organized" filamentous actin. It is thought that this regulation of tight junctions recapitulates the transformation of mammary cells from a leaky to a tight epithelium characteristic of the lactating gland that must maintain a large transepithelial (blood to milk) concentration gradient for ions and macromolecules (29, 35) .
Coincident with the increase in R T , 31EG4 cells also express Na ϩ /H ϩ exchange and Na ϩ -HCO 3 Ϫ cotransport activity in the basolateral, but not the apical, membrane (41) .
The goal of the present work was to determine whether the epithelial Cl Ϫ and Na ϩ channels [cystic fibrosis transmembrane conductance regulator (CFTR) and ENaC, respectively] contribute to the ion and fluid transport properties of the mammary epithelial cell line 31EG4. We reasoned that 31EG4 cells might also express CFTR and ENaC, since 1) the mammary gland and sweat glands are of similar embryological origin and have several characteristics in common, and 2) sweat duct cells express high levels of both these ion channels to allow reabsorption of salt from the fluid that flows down the duct (38) . We used RT-PCR to identify the message and Western blot and immunomicroscopy to identify the proteins. In experiments utilizing transepithelial, microelectrode, and patch-clamp techniques, amiloride-inhibitable changes in voltage and resistance were used to localize ENaC to the apical membrane, and stimulation with cAMP and inhibition by diphenylamine-2-carboxylate (DPC) showed that CFTR is localized to the apical membrane. The roles of ENaC and CFTR in fluid absorption and secretion were determined by measuring amiloride-and cAMP-induced changes in fluid transport (capacitance probe method).
MATERIALS AND METHODS
Cell culture. 31EG4 cells were grown and cultured in DMEM/F-12 medium containing 5% fetal bovine serum (FBS), 5 g/ml insulin, and 5 g/ml gentamicin sulfate. Upon reaching confluency, these cells, passages 6-10, were plated onto Transwell filters (Costar) at a density of 10 5 cells/well. They were grown in DMEM/F-12 medium containing glutamine, 2% FBS, insulin, and gentamicin as described above. When the cells became confluent on the filters, 1 M dexamethasone was added to stop growth and induce differentiation, including formation of tight junctions (48) and polarization of ion transport pathways to the apical and basolateral membranes (41) . RT and transepithelial membrane voltage potential (TEP) were estimated with an EVOM (Epithelial Voltammeter; World Precision Instruments, New Haven CT). The experiments were all carried out between 6 and 9 days after the addition of dexamethasone with no discernible differences in mean TEP or RT.
RT-PCR. Total RNA was extracted from 31EG4 cells by using the RNAzol B method (Teltest) per manufacturer's instructions. First-strand cDNA synthesis was carried out by using 0.5 pg of total RNA, 20 pM oligo(dT) primers, 0.5 mM dNTP mix, and 200 units of Moloney murine leukemia virus reverse transcriptase in a final volume of 20 ml of 50 mM Tris ⅐ HCl (pH 8.3), 75 mM KCl, and 3 mM MgCl2. The RNA and oligo(dT) were annealed by first mixing the two items, heating to 70°C for 2 min, and then cooling on ice, followed by the addition of the remaining reaction components. The mixture was incubated at 42°C for 1 h for first-strand synthesis and then heated to 94°C for 4 min to stop the reaction. The mixture was then diluted 1:5 with sterile distilled water. A control reaction containing no reverse transcriptase was included for each tissue-reverse transcriptase reaction to assure that no genomic DNA was being amplified (data not shown).
PCR was carried out by using oligonucleotide primers (sense gtgattggagctatagcagttgtcg; antisense cccacatctggagcccacagc) designed to cover a 463-bp region of CFTR and a 596-bp region of ENaC (sense tgcaactaccggaacttcacg; antisense gtactgggtgtcattgcagg). The primers (0.5 mM final concentration) were added to a 1-ml aliquot of the first-strand synthesis mixture with the following: 0.2 mM dNTPs (each), 1.25 units of Thermus aquaticus polymerase, PCR buffer with Mg 2ϩ (Boehringer Mannheim), and water to bring the mixture to a total volume of 50 l. The reaction was then overlaid with two drops of mineral oil (Sigma, St. Louis, MO). The mixture was then incubated in a thermal cycler (Stratagene) with the following amplification profile: 1 cycle at 94°C for 4 min; 37 cycles at 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min; and 1 cycle of 72°C for 10 min. The PCR product was run on a 1.5% agarose gel. This product was excised from the gel with a razor and then purified and sequenced by the University of California at Berkeley Sequencing Center.
Western blots. 31EG4 cells were cultured to confluence on filters as described in Cell culture. Proteins were isolated by placing the cells into 100 l of protein isolation buffer containing (in mM) 65 NaCl, 2 MgCl2, 1 EDTA, and 5 Trisacetate, pH 7.4, as well as the following protease inhibitors (in g/ml): 2 aprotinin, 2 leupeptin, 1 pepstatin A, 2 antipan, 100 phenylmethylsulfonyl fluoride, 50 N ␣ -p-tosyl-l-lysine chloromethyl ketone, and 100 N-tosyl-l-phenylalanine chloromethyl ketone. The cells were homogenized by sonicating (Branson, Danbury, CT) on ice for 60 s. Protein concentration was determined using BCA (bicinchoninic acid) protein assay kit (Pierce, Rockford, IL). To separate protein from membranes, we incubated the sample for 4 h at room temperature (RT) in 4% digitonin (wt/vol) in 0.2 M sodium phosphate buffer, pH 8.6. Electrophoresis of the samples was carried out by using Bio-Rad Mini-Protein ready gels (7.5% Tris ⅐ HCl) and the Bio-Rad Mini-Protean cell (Hercules, CA). The running buffer contained 25 mM Tris, 200 mM glycine, and 0.1% SDS. Electroblotting of the proteins onto polyvinylidene difluoride (PVDF) membranes was carried out in a Bio-Rad Mini-Trans-Blot cell at 4°C. The transfer buffer contained 25 mM Tris and 200 mM glycine, pH 8.2-8.5. The blotted PVDF membranes were then blocked in 2% casein [in 0.1% (vol/vol) Tween 20 in PBS] for 1 h at RT and then incubated with a 1:1,000 dilution of primary anti-CFTR antibody overnight at 4°C (pAbECL1-19, peptides corresponding to amino acids 103-109, 109-114, 114-119 of CFTR; a generous gift from Genzyme). Similar procedures were used with a primary anti-ENaC antibody (␤-subunit, a generous gift from Pascal Barbry). The membranes were rinsed three times (5 min each time) with Blotto (5% nonfat dried milk and 0.1% Tween 20 in PBS). The membrane was then incubated in a 1:5,000 dilution of horseradish peroxidase-conjugated anti-rabbit secondary antibody (Sigma) for 1 h at RT, followed by three rinses (5 min each time) with Blotto and then 5 min with PBS. The labeled membranes were developed by using the enhanced chemiluminescence method (NEL-10 Renaissance; NEN).
Immunohistochemistry. 31EG4 cells were grown to confluency on Transwell filters, and the monolayer and filter membranes were punched out, rinsed in PBS for 1 min at RT, and then fixed in 4% formaldehyde-PBS for 30 min. The sample was then rinsed three times, over the course of 10 min, with PBS at RT and placed in 30% sucrose-PBS solution to equilibrate overnight at 4°C. The samples were next embedded in OCT (optimum cutting temperature) compound (Tissue-Tek, Torrance, CA) and incubated at Ϫ20°C for at least 1 h. The samples were then sectioned in 10-to 20-m slices with a cryostat (Leica), placed on Superfrost glass slides (Fisher Scientific), and left overnight to dry at RT. Sections were rinsed for 5 min in PBS and incubated in 10% BSA-PBS solution for 2 h at RT. The slides were then incubated overnight at 4°C in 1:100 (PBS/BSA) dilutions of either polyclonal anti-CFTR or anti-ENaC (␤-subunit). The sections were rinsed three times (10 min each time) in PBS at RT and then incubated in a 1:2,000 dilution of FITC-labeled secondary antibodies for 1 h at RT. The sections were finally rinsed three times (10 min each time) in PBS and mounted on coverslips with Prolong mounting solution (Molecular Probes, Eugene, OR). Images were obtained with the use of a Zeiss Axiophot microscope with a ϫ63 objective.
Immunomicroscopy to identify CFTR in intact mammary gland was also performed on cryosections (4 m) of promptly frozen normal human surgical specimens by using an affinity-purified rabbit antibody [a1468, a synthetic peptide corresponding to amino acids 1468-1480 of CFTR (11, 31) ] at a 1:200 dilution. The specificity of a1468 as a reagent for detecting endogenously expressed CFTR in human colonocytes has been verified in a variety of tissues by immunoblot, immunoprecipitation, and immunostaining (11-13, 18, 31) . Sections were incubated first with a1468 and then with a monoclonal antibody to cytokeratin 19 (ICN Biomedical, Costa Mesa, CA). Sections were then washed and incubated with TRITC-and FITC-conjugated goat F(abЈ) 2 fragments (Tago, Burlingame, CA). Controls for immunostaining included sections stained without primary antibody or with normal rabbit serum.
Fluid transport. Transepithelial fluid flows (JV) were measured by using the capacitance probe technique (22, 24) . A monolayer on a filter (0.5-cm 2 exposed area) was mounted between two water-impermeable Kel F half-chambers. JV was determined with a very sensitive oscillator circuit (Acumeasure 1000; Mechanical Technology, Albany, NY) connected to two probes, one on either side of the tissue, which measure the capacitance between the probe tips and the fluid meniscuses connected to each half-chamber. Ion-linked fluid is driven across the tissue from its apical to basolateral surfaces, or vice versa. Fluid movement across the epithelium is recorded by the changes in probe output voltage. Ports in the bottom of the half-chambers allow for solution and chemical composition changes on either side of the tissue. The capacitance probe in each half-chamber was calibrated by injecting 1-l volumes of fluid and measuring the probe output in millivolts (737 mV/l). This technique has a resolution of ϳ1 nl/min, corresponding to a fluid transport rate approximately one-tenth the average baseline fluid transport rate seen in the present experiments. Voltagesensing and current-passing bridges built into each halfchamber permit continuous monitoring of TEP and R T, the latter being calculated from the voltage deflections in response to transepithelial current pulses of known magnitude. The control Ringer solution for measurements of JV, TEP, and RT contained (in mM) 113.5 NaCl, 5 KCl, 26 NaHC03, 1.8 CaCl2, 0.8 MgS04, 1.0 NaH2P04, and 5.5 glucose, pH 7.4. In some experiments, a cAMP cocktail was added to the control Ringer solution: 500 M 3-isobutyl-1-methylxanthine (IBMX), 100 M 8-(4-chlorophenylthio)adenosine 3Ј,5Ј-cyclic monophosphate (CPT-cAMP), and 12 M forskolin. In other experiments, the following inhibitors were tested: 10-50 M amiloride (to block ENaC), 0.5-1.0 mM DPC (to block CFTR), and 50 M 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB; to block CFTR).
Patch-clamp electrophysiology. Cells were plated on glass coverslips at low density. Patch pipettes were pulled from glass (WPI, Sarasota, FL) on a microelectrode puller (Narishige, Tokyo, Japan) and fire-polished on a microforge (Narishige) to a resistance of 2-10 M⍀ when filled with intracellular solution (see below). Seal resistances were typically 10 G⍀. Data were recorded in the voltage-clamp mode with an amplifier (Axopatch-1D; Axon Instruments, Foster City, CA) connected to a personal computer with an analog-todigital board. Voltage sweeps and currents were recorded with the use of Clampex acquisition software (Axon Instruments). Leak subtraction was not performed on any of the data. Solution changes were made via a seven-node perfusion chamber. The bath chamber was maintained at 37°C with a battery-operated resistive element mounted on the bottom of the chamber and controlled by a battery-operated feedback circuit.
To identify CFTR, whole cell patch pipettes were filled with intracellular solution containing (in mM) 121.5 N-methyl-Dglucamine (NMDG)-gluconate, 13.5 NMDG-Cl, 1.8 ATP, 0.09 GTP, 9 HEPES, and 9 glucose. Extracellular solution contained (in mM) 141 NaCl, 4 KCl, 1 KH2PO4, 1 MgSO4, 1 CaCl2, 10 HEPES, and 10 glucose, with either 10 M forskolin or 2 mM DPC added. Voltage sweeps were run from Ϫ80 mV to 100 mV, with data sampled at a frequency of 10 kHz.
Whole cell experiments were also performed in an attempt to identify ENaC in single 31EG4 cells. Cells were plated at low density and then treated with 1 M dexamethasone for roughly 24 h before the experiment to increase cellular differentiation. Pipette solution for these experiments contained (in mM) 121.5 NMDG-gluconate, 2.7 NMDG-Cl, 0.9 CaCl 2, 0.9 MgCl2, 9 HEPES, 4.5 glucose, 2.25 ATP, 0.09 GTP, and 9.9 EGTA. Two different extracellular solutions were employed for these experiments. Extracellular Na-gluconate solution contained (in mM) 145 Na-gluconate, 7 NaCl, 1 CaCl 2, 1 MgCl2, 10 HEPES, and 5 glucose. Extracellular NaCl solution contained (in mM) 150 NaCl, 1 CaCl 2, 1 MgCl2, 10 HEPES, and 5 glucose. Voltage sweeps were run from Ϫ80 mV to 100 mV, with data sampled at a frequency of 10 kHz. Conductances values were obtained by measuring the slopes of the current-voltage (I-V) curves at around 20 mV.
Transepithelial and microelectrode electrophysiology. The recording setup and perfusion system has been described previously (36) . Transwells with confluent 31EG4 monolayers and R T Ͼ 300 ⍀ ⅐ cm 2 were used for the electrophysiology measurements. The monolayers on filters were mounted on a nylon mesh support and clamped into a modified Ussing chamber. R T and the ratio of the apical to basolateral membrane resistance (a) were obtained by passing 4-A current pulses across the tissue and measuring the resultant changes in TEP and voltages across the apical (V A) and basolateral membranes (V B). Current pulses were bipolar, with a period of 3 s applied at various time intervals. R T is the resulting change in TEP divided by 2 A, and a is the ratio of voltage change in V A divided by the change in VB (a ϭ ⌬VA/⌬VB). The current-induced voltage deflections were digitally subtracted from the records for clarity. Short-circuit current (I sc) measurements were performed with the use of similar chambers and electrophysiological apparatus, with TEP clamped to zero and using solution and resistance compensation. Pulses of 5 mV were often utilized to measure R T in these experiments. The control Ringer solutions (in mM) used for measurements of TEP, R T, and Isc are identical to those used for the measurements described in Fluid transport.
Calculating membrane and shunt resistances and equivalent electromotive forces. The intracellular measurements were analyzed with an equivalent circuit model (see Fig. 1 ) that has been previously described (26, 32) . We used the microelectrode data to calculate resistances (R, in ⍀ ⅐ cm 2 ) and equivalent electromotive forces (E, in mV) for the apical and basolateral membranes and the shunt for 31EG4 cells. The general approach used (26) was to measure TEP as well as V A and VB and determine a values (a ϭ ⌬VA/⌬VB ϭ RA/RB) in control conditions and then during treatment with amiloride. This allowed us to calculate shunt resistance (RS). It was assumed that amiloride only altered EA and RA. Calculation of equivalent circuit parameters was based on the following steady-state considerations
where i is the loop current generated by the difference in V A and VB, and EA and EB are the apical and basolateral membrane potentials, respectively, that would be recorded if RS were infinite. By definition
R T is given by
Combining Eqs. 1 and 2 gives
Similarly,
Using Eq. 3 before and after (denoted with asterisk) amiloride, we obtain
Using Eqs. 4-6 and the data collected before and shortly after amiloride treatment, we calculated R S and then RA, RB, . PCR products for epithelial Na ϩ channel (ENaC; 596 bp) and cystic fibrosis transmembrane conductance regulator (CFTR; 463 bp). The amplified products were run on a 1.5% agarose gel and stained with ethidium bromide. The 100-bp ladder is shown at left (ladder). EA, and EB for control and amiloride-treated conditions. This calculation assumes that amiloride affects only the apical membrane, while RS and RB remain constant.
Data are presented as means Ϯ SE, unless otherwise specified. Student's unpaired t-test was used to compare groups, and P Ͻ 0.05 is considered statistically significant.
RESULTS
PCR, Western blot analysis, and immunocytochemistry. PCR and Western blot analysis were performed on 31EG4 cells grown to confluence in the presence of dexamethasone to increase differentiation of the cells. The PCR experiments summarized in Fig. 2 showed that mRNA for both ENaC and CFTR was present in 31EG4 cells. In Fig. 3 , Western blots with bands at 170 (CFTR) and 85 kDa (ENaC ␤ subunit) indicate that both proteins were being made.
Immunomicroscopy was performed on 31EG4 cells grown to confluence on filters. As shown in Fig. 4 , A and B, both ENaC and CFTR appeared to be expressed in the apical portions of the 31EG4 cells. CFTR immunoreactivity was also detected in intact human mammary glands by indirect immunofluorescence (Fig. 5) . The predominant site of staining was the apical domain of the epithelial cells lining the ducts of the mammary gland. Cytokeratin staining identified duct cells and demonstrated tissue architecture for orientation.
Transepithelial and patch-clamp electrophysiology. 31EG4 monolayers were mounted in Ussing chambers and then treated with amiloride (to block ENaC), followed by forskolin (to stimulate cAMP production and active PKA) and DPC (to block CFTR). As shown in Fig. 6 , 10 M amiloride in the apical solution decreased Fig. 6 . Effects of amiloride, forskolin, and diphenylamine-2-carboxylate (DPC) on short-circuit current (Isc) of 31EG4 monolayers. Cells grown to confluency on filters were mounted in the chamber, and Isc was measured. Spikes in the Isc trace represent changes induced by briefly clamping epithelium to 5 mV. Apical addition of amiloride caused Isc to decrease from ϳ13.5 A/cm 2 to 11.5 A/cm 2 . Subsequent treatment with 10 M forskolin (to increase cAMP) caused Isc to increase from 13.5 A/cm 2 to 15 A/cm 2 , and DPC reduced Isc to 9 A/cm 2 . Experiment is typical of 4 others. I sc , although not to zero, indicating that there was some residual anion secretion or cation absorption. The identity of this ionic current has not been identified. Instead, we concentrated on determining the potential contribution of ENaC and CFTR to the ion transport properties of 31EG4 cells. In the presence of apical amiloride, forskolin (10 M) increased I sc , and subsequent addition of apical DPC (500 M) decreased I sc . In five experiments, amiloride decreased I sc by 2.5 Ϯ 0.7 A/cm 2 (mean Ϯ SE); in the presence of amiloride, forskolin increased I sc by 7.8 Ϯ 1.4 A/cm 2 , and subsequent addition of DPC decreased I sc by 5.5 Ϯ 0.8 A/cm 2 . Whole cell patch-clamp measurements were also performed on 31EG4 cells. As shown in Fig. 7A , forskolin increased cellular conductance from 1.7 nS to 34 nS and shifted the reversal potential from about Ϫ20 mV to Ϫ25 mV. DPC reversed the forskolin-induced changes by bringing the reversal potential and the conductance back to their resting, baseline levels. Amiloride-sensitive currents were also identified in whole cell patch-clamp experiments. These currents were quite small in the resting state (Fig. 8A) , so the inhibitory effects of amiloride were difficult to identify in every cell. Figure 8A shows an experiment in which the cells were incubated in a NaCl-containing Ringer solution; the I-V curve showed small, linear currents (mean whole cell conductance ϭ 0.6 nS, reversal potential ϭ Ϫ15 mV). Conductance was inhibited by amiloride to 0.3 nS, and the reversal potential shifted in the negative direction to Ϫ22 mV, consistent with inhibition of ENaC. Two other experiments were also performed on cells in which the bathing solution was Na-gluconate Ringer (to eliminate contribution of Cl Ϫ currents), and amiloride had similar effects on cell currents and conductances, although the absolute conductances were, for some unexplained reason, significantly higher. Figure 8B summarizes the results from two experiments in which the cells were incubated in a NaCl-containing Ringer and two other experiments in which the cells were bathed in Na-gluconate Ringer.
Intracellular recordings, calculated electromotive forces, and cell membrane resistances. Figure 9 shows a typical intracellular microelectrode recording with resting, unstimulated levels of V A , V B , TEP, R T , and R A /R B . When a cocktail of forskolin, CPT-cAMP, and IBMX was added to the apical bath, there was a rapid and reversible increase in TEP, since V A depolarized more than V B ; concomitantly, R T dropped and R A /R B decreased from 3.5 to 2. All these responses are consistent with a conductance increase of an apical membrane channel whose equilibrium potential is depolarized with respect to V A .
As summarized in Table 1 , the mean resting R T and TEP are 829 ⍀ ⅐ cm 2 and Ϫ5.9 mV, respectively. The TEP is apical-side negative, since V B is more hyperpolarized than V A . In addition, the mean R A /R B of ϳ3 indicates that the apical membrane has a threefold greater resting resistance than the basolateral membrane. Table 1 also summarizes the cAMP-induced changes in membrane voltages and resistance, which are all consistent with an increase in apical membrane conductance. From the summary data in Table 1 , the calculated (Ohm's law) equivalent I sc of the resting Fig. 8 . Effect amiloride on whole cell patch-clamp current, I-V relationship, and conductance in NaCl and Na-gluconate Ringer solutions. A: whole cell patch recording of a resting cell (control) with a basal conductance in NaCl solution of 0.6 nS and a reversal potential of Ϫ15 mV. Addition of 10 M amiloride (ϩamil) caused conductance to decrease to 0.3 nS and shifted the reversal potential to Ϫ22 mV. B: summary of 2 experiments performed with NaCl bathing solutions (F) and 2 experiments performed with Na-gluconate solutions (E). Average resting conductance was 1.2 nS in NaCl solution and 0.7 nS after amiloride. Average resting conductance in Na-gluconate solution was 16.5 nS, decreasing to 8.8 nS after amiloride. and 9 and summarized in Table 1 are consistent with the hypothesis that cAMP activates apical membrane CFTR and increases Cl Ϫ transport from the basolateral to the apical surface at a rate of ϳ5 A/cm 2 . Because the CFTR-blocker DPC appeared to block the forskolin-induced increases in I sc (Fig. 6) , it was expected that the cAMP-induced changes in cellular electrophysiology would also be blocked by NPPB, another fairly specific CFTR blocker (25, 40) . In the presence of apical NPPB (see Fig. 10 ), the cAMP cocktail had relatively little or even opposite effects on R T , R A /R B , TEP, V A , and V B (compare with the following control or Fig. 10 ). For example, the slow decrease in TEP shows that V B depolarized faster than V A in the presence of NPPB, opposite to what is seen for the cAMP-induced changes in TEP and membrane potential. Practically identical NPPB-induced responses were observed in four experiments. In summary, elevating cell cAMP depolarized V A and V B , decreased R A /R B and R T , and increased TEP (Table 1) . These changes and their blockade by apical NPPB (or DPC, in Fig. 6 ) are all consistent with the presence of CFTR at the apical membrane.
Intracellular recordings were also used to measure the effects of amiloride on membrane voltages and resistances. Results from a typical microelectrode experiment are shown in Fig. 11 where apical amiloride (20 M) decreased TEP and increased R T . R A /R B increased by more than a factor of six, and V A hyperpolarized by 24 mV. All the electrophysiological changes were reversed when amiloride was removed from the apical bath. Similar amiloride-induced changes were obtained in 16 experiments and are summarized in Table 1 . These results indicate that amiloride blocked Na ϩ entry through apical ENaC. Addition of 20 M amiloride to the basolateral solution caused small and equal depolarizations (Ͻ5 mV) in V A and V B with no change in TEP, a 30% drop in R A /R B , and a 5% increase in R T (n ϭ 3; not shown). These small alterations in membrane voltage and resistance may have been due to the effect of amiloride on the basolateral Na ϩ /H ϩ exchanger (41) and secondary changes in cellular pH.
The data summarized in Table 1 were used as described in MATERIALS AND METHODS to calculate resistances and electromotive forces for the apical and basolateral membranes and shunt for 31EG4 cells in Values are means Ϯ SE; n ϭ no. of experiments. Amiloride (20 M) and cAMP induced changes (⌬) in membrane voltage and resistance. Differences between control (untreated) and cAMP and between control and amiloride are significant in all cases (P Ͻ 0.01). TEP, transepithelial potential; RT, transepithelial resistance; VA and VB, voltages across the apical and basolateral membranes, respectively; RA/RB, ratio of resistance across apical and basolateral membranes.
control and during amiloride. The results of these calculations are summarized in Table 2 . The assumption (MATERIALS AND METHODS) that amiloride had no affect on R S or R B was tested by allowing either R S or R B to change up to Ϯ20% after amiloride treatment. In both cases, all of the calculated parameters were within 0.5 SD of the mean values shown in Table 1 , indicating that within the error of these experiments, the effects of amiloride were restricted to the apical membrane.
Comparison of amiloride effects under control and cAMP-or ATP-treated conditions. Previous experiments have shown increased Na ϩ and fluid absorption in cystic fibrosis (CF) tissues (7, 20, 24) , and heterologous expression of CFTR is known to decrease the activity of ENaC in both frog oocytes (27) and MadinDarby canine kidney cells (43, 44) . However, it also has been shown that ENaC activity is much reduced in freshly isolated CF sweat ducts that lack functional CFTR (38) . Because 31EG4 cells express both CFTR and ENaC, we tested whether cAMP treatment could alter ENaC activity. A typical experiment is shown in Fig. 12A . In the first part of the experiment, amiloride (20 M) hyperpolarized V A by 20 mV and increased baseline R A /R B by a factor of 10, from 0.25 to 2.5; in addition, R T increased and TEP decreased. Subsequent addition of the cAMP cocktail, in the continued presence of amiloride, depolarized V A by ϳ24 mV and decreased R A /R B to its baseline level in control Ringer. cAMP addition also decreased R T and increased TEP. Similar results were obtained in two other experiments (not shown). The voltage changes were somewhat larger than those exhibited in the absence of amiloride, probably because amiloride increased the driving force for Cl Ϫ exit across the apical membrane. These results show that the blockade of ENaC activity with amiloride does not appreciably alter the cAMP-induced changes in membrane voltage and resistance.
In contrast, the data in Fig. 12B show that apical amiloride caused significantly smaller electrophysio- (Table 3 ). Equivalent circuit calculations of membrane resistances and voltages were also performed on the subset of microelectrode experiments in which amiloride was added to monolayers that had been treated with cAMP. Results from these calculations have been summarized in Table 4 . Compared with control conditions (Table 2) , cAMP caused R A to decrease from 1,958 ⍀ ⅐ cm 2 to 157 ⍀ ⅐ cm 2 ; in the presence of cAMP, amiloride had essentially no effect on R A ( Table 4) .
The apparent reduction in ENaC activity might be secondary to cAMP-induced changes in membrane voltage or resistance. This possibility was tested by activating another set of apical Cl Ϫ channels to see if they also reduced the effects of amiloride. We have found that the apical membrane of 31EG4 cells contains P2Y receptors that, when activated by ATP, elevate cell Ca 2ϩ (Blaug and Miller, unpublished observations) and produce membrane voltage and resistance changes very similar to those produced by elevating cell cAMP: in seven experiments, apical ATP (50 M) depolarized V A by ϳ17 mV, from Ϫ43.9 Ϯ 1.7 mV to Ϫ26.9 Ϯ 1.1 mV; R A /R B decreased from 3.5 Ϯ 0.2 to 1.8 Ϯ 0.3, and R T decreased by 109 ⍀ ⅐ cm 2 , from 518 Ϯ 39 ⍀ ⅐ cm 2 to 409 Ϯ 20 ⍀ ⅐ cm 2 (means Ϯ SE), changes not significantly different from those produced by cAMP (Table 1) . If the reduction in ENaC activity were entirely dependent on cAMP-induced changes in membrane voltage or resistance, then activation of Ca 2ϩ -activated Cl Ϫ channels by ATP should also inhibit the amiloride-induced changes in TEP and R T .
The experiment summarized in Fig. 12C tested this notion by comparing the amiloride responses in the same monolayer, first in the presence of cAMP (top) and then in the presence of ATP (bottom). Identical results were obtained independent of order. Apical amiloride characteristically decreased TEP and increased R T , and these responses were reversible. In the presence of cAMP (which increased TEP and decreased R T ), amiloride had no significant effect on TEP or R T . The cAMP cocktail and amiloride were removed, and the monolayer was returned to control Ringer for 30 min. Figure 12C , bottom (same monolayer), shows that the addition of ATP to the apical bath had effects on TEP and R T nearly identical to those produced by cAMP. In the presence of ATP, amiloride decreased TEP and increased R T by amounts that were very similar to those in control, untreated monolayers.
These results are summarized in Table 5 . The amiloride-induced changes in TEP and R T are significantly reduced in the presence of cAMP but not in the presence of ATP.
Fluid transport. Rates of transepithelial fluid movement along with TEP and R T were measured under baseline, control conditions in 31EG4 monolayers grown on filters and then after the addition of either a cAMP-stimulating cocktail or amiloride to the apical bath. Figure 13 summarizes the data from a cAMP experiment. The baseline J V was ϳ3.5 l ⅐ cm Ϫ2 ⅐ h
Ϫ1
, in the absorption direction. Addition of cAMP cocktail reversibly altered TEP and R T , as in the electrophysiology experiments. Consistent with increased Cl Ϫ secretion, cAMP reversed the direction of steady-state fluid flow from absorption to secretion (approximately Ϫ2.5 l ⅐ cm Ϫ2 ⅐ h Ϫ1 ); this J V response was partially reversible.
In control Ringer, the direction and magnitude of fluid transport was variable, independent of time in culture (6-9 days).
1 Of 17 cultures (summarized in Fig.  14) , 9 exhibited a baseline absorption (range: 0.5 to 7.6 l ⅐ cm Ϫ2 ⅐ h
) and 8 exhibited a baseline secretion (range: 0.75 to Ϫ5 l ⅐ cm Ϫ2 ⅐ h Ϫ1 ). cAMP always caused fluid secretion, 2 which ranged from Ϫ1 to Ϫ8 l ⅐ cm Ϫ2 ⅐ h
. The cAMP-induced changes in TEP and R T were very similar for both fluid-absorbing and -secreting tissues and were very similar to the electrophysiological results summarized in Table 1 . In six other monolayers, two absorbing and four secreting (Fig. 14) , apical amiloride increased the mean secretory rate to Ϫ6.7 Ϯ 4.8 l ⅐ cm Ϫ2 ⅐ h Ϫ1 (mean Ϯ SD). In Fig. 15 we plotted the magnitude (͉⌬J V ͉) of the cAMP-induced fluid-secretory response as a function of steady-state J V . ͉⌬J V ͉ was largest for those monolayers that absorbed fluid in the baseline condition (before addition of cAMP) and lowest for those that secreted fluid. Figure 15 also shows that for monolayers in the baseline condition (no amiloride or cAMP), R T was 1 In a comparison of 6-, 8-, and 14-day-old cultures from the same set of cells, the mean (ϮSE) JV was Ϫ0.9 Ϯ 1.6 (n ϭ 8; 4 absorbing), Ϫ2.6 Ϯ 0.8 (n ϭ 9; 3 absorbing), and Ϫ3.3 Ϯ 2.9 l ⅐ cm Ϫ2 ⅐ h Ϫ1 (n ϭ 11; 3 absorbing), respectively. These values are not statistically different from each other (P Ͼ 0.3). 2 In two experiments (not shown), net fluid absorption was increased by cAMP. As expected, cAMP decreased RT in these two experiments, but TEP also decreased, which is opposite to the results obtained in all the other experiments. This finding suggests that the electrochemical gradient for Cl Ϫ was inward in these two cases, as was previously shown in bovine trachea (46). Equivalent circuit calculations are derived from summary data in Table 1 . Values are means Ϯ SE. RA, RB, shunt resistance (RS), and electromotive forces across the apical and basolateral membranes (EA and EB, respectively) were calculated in control and in the presence of amiloride. Asterisks signify the assumption that RB and RS are not altered by apical amiloride. Fig. 12 . Amiloride-induced changes in membrane voltage and resistance in the absence and presence of cAMP-elevating cocktail. A: amiloride caused characteristic changes in VA, VB, RA/RB (ᮀ), TEP, and RT (ᮀ), and subsequent addition of cAMP cocktail in the continued presence of amiloride produced cAMP responses similar to those measured in control Ringer (Table 1) . B: 31EG4 cells were first treated with cAMP cocktail, which caused characteristic depolarization of VA, decrease of RA/RB (E), and increase in TEP. Subsequent addition of amiloride in the continued presence of cAMP produced no significant changes in RT (ᮀ), RA/ RB, TEP, and VA. Summary data are shown in Table 1 . C: amiloride-induced changes in TEP and RT (ᮀ) in the presence and absence of cAMP or ATP were measured in the same monolayer. Top: control TEP and RT were Ϫ5.5 mV and 950 ⍀ ⅐ cm 2 , respectively. Apical amiloride reversibly decreased TEP (1.5 mV) and increased RT (125 ⍀ ⅐ cm 2 ). The tissue was returned to control Ringer, and then cAMP cocktail was added to the apical bath; TEP increased by 1.7 mV and RT decreased by 110 ⍀ ⅐ cm 2 . In the presence of cAMP, apical amiloride produced no changes in TEP or RT. The monolayer was then returned to control Ringer (30 min); TEP and RT returned to their control levels. Bottom: apical ATP increased TEP (2 mV) and decreased RT (200 ⍀ ⅐ cm 2 ). In the presence of ATP, apical amiloride reversibly decreased TEP by 1 mV and increased RT by 75 ⍀ ⅐ cm 2 . Subsequent ATP removal decreased TEP and increased RT.
highest in monolayers that absorbed fluid and lowest in monolayers that secreted fluid in the baseline condition.
DISCUSSION
CFTR, ENaC, ion transport, tight junctions, and mammary gland physiology. The normal (i.e., nontransformed) mammary epithelial cell line 31EG4 expresses CFTR and ENaC in the apical membranes. Messages for both CFTR and ENaC were identified, and Western blots showed that proteins with the expected molecular sizes were present. Immunomicroscopy of the cultures and intact human mammary tissue (Figs. 4 and 5) indicated that both channels are located either in or very close to the apical membrane. Although the immunomicroscopy could not determine the precise membrane locations of CFTR and ENaC, electrophysiology indicated that these channels were active in the apical membranes of the cells.
In the short-circuited condition, or when open-circuit TEP and R T data were used to calculate equivalent I sc , 31EG4 cells exhibited currents of 2-7 A/cm 2 that were blocked by apical, but not basolateral, amiloride, consistent with the presence of functional apical ENaC. Whole cell patch-clamp measurements also demonstrated amiloride-inhibited currents and conductance as well as linear I-V curves expected for ENaC. Microelectrode experiments showed that amiloride hyperpolarized E A and caused large increases in R A , consistent with blocking apical ENaC. The comparatively smaller amiloride responses in the patch-clamp vs. the microelectrode experiments is probably due to poor seals in the patch-clamp experiments and the relatively low resistance of the shunt compared with the cellular pathway.
cAMP depolarized E A and reduced R A by more than a factor of 10 (compare Tables 2 and 3 ) and also increased basolateral-to-apical anion current (likely Cl Ϫ or HCO 3 Ϫ ) by 5 A/cm 2 ; these changes were inhibited by apical DPC or NPPB. Patch-clamp experiments also showed forskolin-stimulated, DPC-inhibitable currents and conductance as well as linear I-V curves. cAMP treatment also may have altered the voltage or conductance properties of other Cl Ϫ channels at the basolateral membrane (46), but clearly a major effect of cAMP stimulation was to activate apical CFTR. 31EG4 cells also express apical membrane ATP-activated Cl Ϫ channels and apical and basolateral K ϩ channels (unpublished observations). These channels may contribute to the negative values of E A and E B and could also be important for ion and fluid secretion (and absorption) that occur in both baseline (control) and cAMPstimulated conditions.
Our calculations that R S (1,000-1,400 ⍀ ⅐ cm 2 ) is smaller than total cellular resistance (R cell ϭ R A ϩ R B ϭ 2,100-2,500 ⍀ ⅐ cm 2 ) indicate that although R S (Table 1 ) is large compared with many tissues with "leaky" tight junctions (R S Ͻ 100-200 ⍀ ⅐ cm 2 ; see Ref. 14) , it is apparently still a major pathway for current flow. The low value of R S compared with R cell also helps keep the TEP in 31EG4 cells relatively small, Ϫ6 mV, similar to the situation in leaky epithelia (32) . As discussed below, this tight junctional permeability also contributes to the ability of 31EG4 cells, a clonally derived cell line (39, 42, 48) with roughly equal distributions of ENaC and CFTR in all the cells of the monolayer (Figs. 4 and 5) , to both secrete and absorb fluid ( Fig. 14 and footnote 1 ). It will be interesting to determine whether acinar and ductal cells in situ retain this capability or if the present results represent a culture-to-culture variation in the ratio of secretory (acinar?) to absorptive (ductal?) epithelial cells.
The present demonstration of functional ENaC in the apical membrane of 31EG4 cells is consistent with previous experiments showing amiloride-sensitive Na ϩ absorption across short-circuited primary cultures of both midpregnant and lactating mammary gland cells (3) . Similarly, localization of CFTR to the luminal Equivalent circuit calculations are derived from summary data in Table 3 . Values are means Ϯ SE. The cAMP-induced changes in apical membrane resistance and electromotive force are compared in the absence and presence of amiloride. Asterisks signify the assumption that RB and RS are not altered by apical amiloride.
membrane of 31EG4 cells is consistent with the presence of apical CFTR in native human mammary duct cells (Fig. 5) . Our results therefore indicate that ENaC and CFTR of mammary duct cells may be involved in generating or maintaining the characteristic Na ϩ and Cl Ϫ concentrations of milk (34) .
ENaC and CFTR also may be involved in the abnormal generation and accumulation of breast fluid (socalled cystic disease of the breast) that occurs in 7-10% of women in Western countries, mainly in the premenopausal decade. There is now strong evidence to indicate that these women are at a two-to fourfold higher risk of later developing breast cancer (5, 8, 10, 16, 30) . Although the chemical compositions of these fluid-filled cysts are quite complicated (1, 9) , there appears to be a distinct pattern of Na ϩ and Cl Ϫ concentrations (17, 33) that could reflect alterations in luminal CFTR and ENaC activity. Clinically, it has been shown that tamoxifen reduces the number and size of such cysts (28) . Because tamoxifen can block Cl Ϫ channels (15, 47) , it may be exerting its therapeutic effect by decreasing fluid secretion.
Effects of cAMP on CFTR and ENaC: evidence for cross talk? cAMP caused, in addition to the expected increase in CFTR activity and consequent drop in R T and R A , an almost complete inhibition of the amilorideinduced changes in TEP, R T , R A /R B , and R A ( Fig. 12B ; Tables 1-4 ). This apparent inhibitory effect of activated CFTR on ENaC may be understood by a direct interaction between the channels or indirectly by other mechanisms. 1) The amiloride-induced voltage re- Values are means Ϯ SE. Control values were measured in 31EG4 monolayers. ATP-and cAMP-induced changes in TEP and RT are statistically indistinguishable from control values. Amiloride-induced changes were then measured in the absence or presence of ATP or cAMP. Amiloride-induced changes in TEP and RT in the presence of cAMP were significantly reduced compared with those observed in control or in the presence of ATP (P Ͻ 0.001). Fig. 13 . cAMP-induced stimulation of steady-state fluid secretion. Apical addition of the cAMP cocktail reversed the direction of net steady-state fluid transport from absorption (3.5 l⅐cm Ϫ2 ⅐ h Ϫ1 ) to secretion (Ϫ3.0 l ⅐ cm Ϫ2 ⅐ h Ϫ1 ) and simultaneously increased TEP and decreased RT consistent with the electrophysiological responses summarized in Table 1 . The obligatory control-to-control solution change (probes out; see MATERIALS AND METHODS) during the first 40 min produced very little change in JV, TEP, and RT (ᮀ). Removal of cAMP from the apical bath brought JV back to absorption at ϳ1.0 l ⅐ cm Ϫ2 ⅐ h Ϫ1 . The electrical changes were also reversible.
sponses may have been decreased because cAMP depolarized the apical membrane and reduced the driving force for Na ϩ entry. However, similar inhibitory effects were seen in other experiments (not shown) in which the apical membrane was current-clamped close to its resting level in the absence of cAMP.
2) The cAMPinduced increase in apical membrane conductance may have been sufficiently large to mask the amilorideinduced changes in membrane resistance and voltage. Against that possibility are the data summarized in Fig. 12 and Table 5 , which show that cAMP and ATP had practically identical effects on TEP and R T (and V A and R A /R B ; not shown) but that the amiloride responses were totally obliterated in cAMP and relatively unaffected by ATP. However, the conclusion that activation of CFTR inhibits ENaC is not certain (27, 43) because the cAMP-induced, but not the ATPinduced, increase in apical membrane conductance may have been sufficient to mask the amiloride-induced changes in membrane resistance and voltage. A more definitive experiment would be to measure the amiloride-induced changes in R A /R B in ATP-vs. cAMPtreated cells. However, we have been unable to hold microelectrode penetrations long enough to make this comparison.
Critical role of tight junctions in ion and fluid transport. The present data based on 31EG4 monolayers and evidence from other epithelial systems (25, 37) indicate that net vectorial transport depends critically on ENaC and CFTR operating in concert with the tight junctions. Fluid absorption is mainly controlled by the transport of Na ϩ down its electrochemical gradient through apical ENaC, while fluid secretion is regulated by cell-to-lumen movement of Cl Ϫ and/or HCO 3 Ϫ through cAMP-stimulated CFTR. In both cases, the obligatory movement of counterions (cations to accompany active Cl Ϫ secretion and anions to accompany active Na ϩ absorption) likely takes place predominantly through leaky tight junctions driven by the basal side-positive TEP. Thus "leaky" tight junctions are important for the ability of an epithelium to exhibit both absorption and secretion.
The net balance between secretion and absorption in 31EG4 cells may be determined in part by the activity of CFTR in the apical membrane. This idea is consistent with the observation that fluid absorption increases monotonically with R T , and the cAMP-induced alteration in J V is smallest for control tissues that secreted fluid and largest for control tissues that absorbed fluid (Fig. 15) . Thus, when CFTR conductance is lowest, R T is highest, and the monolayers absorb Na ϩ , Cl Ϫ , and fluid. Subsequent elevation of cell cAMP could then activate the maximum number of CFTR channels and produce the maximum alteration in J V (Fig. 15) . Conversely, cultures that have a relatively low R T may have a relatively large complement of active CFTR in the apical membrane and therefore secrete fluid in the basal state (Fig. 15) ; secretion is increased by amiloride block of ENaC (Fig. 14) .
The tight junctions will also play a role in determining secretion vs. absorption because the intraepithelial current (i ϭ TEP/R S ) (32) , determined in part by the low resistance of the junctions (R S Ͻ R A ϩ R B ), hyperpolarizes V A , thereby increasing Na ϩ entry (ENaC) into and Cl Ϫ (CFTR) exit from the cells. During cAMP stimulation V A depolarizes by 18 mV (Table 1) , and the increase in fluid secretion indicates that the net electrochemical gradient for Cl Ϫ is outward across the apical membrane.
These considerations emphasize the importance of the integrated activities of ion channels, tight junctions, and ion transporters in determining the direction of net Cl Ϫ movement through CFTR. They also suggest a functional distinction among epithelia with apical ENaC and CFTR. Epithelia with tight junctions that are essentially impermeable to ions can only absorb salts and fluid via the cellular pathway. In these tissues, the shunt current is zero, and V A is sufficiently depolarized such that the electrochemical driving forces for both Cl Ϫ and Na ϩ are inward across the apical membrane. Therefore, activation of CFTR with cAMP elicits absorption of Cl Ϫ , Na ϩ , and fluid through the cells (see footnote 2 in Fluid transport). Examples include human sweat ducts and bovine trachea (38, 46) and also may be true in the lactating mammary gland, which has large lumen-negative TEP (Ϫ35 mV), characteristic of all tight epithelia, and low concentrations of Na ϩ and Cl Ϫ in the milk (35) . In contrast, epithelia like 31EG4 cells that have relatively leaky junctions generate a shunt current that hyperpolarizes V A , increasing Cl Ϫ exit (CFTR) and Na ϩ entry (ENaC) across the apical membrane. The conductance of the shunt to anions and cations and the existence of a TEP permit these cells to either secrete or absorb salts and fluid, depending on the ratio of ENaC to CFTR conductance and on the direction and magnitude of the electrochemical driving forces for these ions across the apical membrane. This also appears to be the case in airway submucosal glands. When CFTR is activated, these cells secrete fluid driven by the transport of HCO 3 Ϫ and Cl Ϫ through CFTR (2, 23, 45) with Na ϩ following through ionpermeable tight junctions to maintain electroneutrality. In CF, when CFTR is inactive, submucosal gland cells absorb Na ϩ (through ENaC), Cl Ϫ (through the paracellular pathway), and fluid (25) . This capability to both secrete and absorb fluids also may be characteristic of the nonlactating mammary gland (with its leaky tight junctions) (35) .
